Maryland 2023 Regular Session

Maryland Senate Bill SB965

Introduced
2/27/23  
Refer
2/27/23  
Refer
3/14/23  
Report Pass
3/23/23  
Engrossed
3/27/23  
Refer
3/28/23  
Refer
4/5/23  
Report Pass
4/6/23  
Enrolled
4/7/23  
Chaptered
5/3/23  

Caption

Cancer Screening - Health Insurance and Assessment of Outreach, Education, and Health Disparities

Impact

The legislation modifies existing health insurance provisions to include coverage for lung cancer screening and diagnosis in addition to breast cancer. Key components of the bill involve an assessment by the Maryland Department of Health of current outreach efforts and health disparities affecting cancer screening. This assessment will consider the availability of biomarker testing and will involve a stakeholder work group consisting of representatives from historically underserved communities. These measures aim to address inequities in healthcare access and to ensure that all Marylanders are informed about cancer screening options.

Summary

Senate Bill 965 establishes a Breast and Lung Cancer Screening Awareness Program in the Maryland Department of Health. This initiative is focused on educating the public about the importance of early screening for breast and lung cancer, and about the insurance benefits available for such screenings under Maryland law. It requires insurers to provide coverage for breast cancer diagnostics, including various imaging methods, and to limit copayments and deductibles for these services to ensure accessibility for patients. By promoting awareness and easing financial burdens, the bill aims to improve cancer screening rates among Maryland residents.

Sentiment

The sentiment around SB 965 appears largely positive, particularly among health advocacy groups and lawmakers focused on public health. Supporters highlight the necessity of expanding cancer screening efforts as a means to save lives and improve overall health outcomes. However, there may be some concerns regarding the financial implications for insurers and the healthcare system as coverage requirements are expanded, indicating a mixed response from the insurance sector, which may view these mandates as an added burden.

Contention

Notable points of contention surrounding SB 965 include the potential cost impacts on insurance providers and the challenge of effectively implementing the outreach program to reach underserved populations. Additional concerns have been raised regarding ensuring that the necessary resources for education and public engagement are adequately funded. The balance between improving access to critical health services and maintaining financial sustainability for health insurers and the state healthcare budget will likely be ongoing discussions as the bill is enacted.

Companion Bills

MD HB815

Crossfiled Cancer Screening - Health Insurance and Assessment of Outreach, Education, and Health Disparities

Previously Filed As

MD HB2097

Health insurance; coverage requirements for prostate cancer screenings.

MD SB1314

Health insurance; coverage requirements for prostate cancer screenings.

MD AB263

Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE)

MD SB264

Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE)

MD SB219

Imposing certain health insurance coverage requirements for screening and diagnostic examinations for breast cancer.

MD HB859

Access to Health Insurance for Child Care Professionals - Outreach

MD SB611

Access to Health Insurance for Child Care Professionals - Outreach

MD S1494

Insurance Coverage for Breast Cancer Screening

MD A1142

Expands requirements for health insurance carriers concerning prostate cancer screening. *

MD HCR36

Requesting The Auditor To Assess The Social And Financial Effects Of Proposed Mandatory Health Insurance Coverage For Colorectal Cancer Screenings.

Similar Bills

No similar bills found.